fig3
Figure 3. Recurrence in patients treated with DAAs after curative treatment for HCC according to the number of previous HCC treatments. The recurrence rates increased as the number of previous HCC treatments increased (P < 0.0001, log-rank test). HCC: hepatocellular carcinoma; DAA: direct-acting antiviral; Tx: treatment
